Carlton H. Ingram Veterans’ Benefits Protection Act
- Sponsor
- Sen. Blumenthal, Richard [D-CT]
- Committees
- Veterans' Affairs Committee (primary)
- Last action
- Apr 29, 2026
Bottom line
The Carlton H. Ingram Veterans' Benefits Protection Act seeks to ensure that veterans' disability ratings accurately reflect their underlying conditions by excluding the mitigating effects of ongoing treatment, potentially increasing or maintaining higher disability compensation for many.
What it actually does
This bill amends title 38, United States Code, to require the Department of Veterans Affairs (VA) to discount the beneficial effects of medication or treatment when establishing a veteran's disability rating, provided evidence can establish a baseline without those effects. It aims to ensure that a veteran's disability is rated based on its underlying severity, not on how well symptoms are managed by ongoing treatment. The bill also clarifies that veterans can still seek compensation for new disabilities or aggravations caused by the medication or treatment itself.
Proponents argue
Proponents argue that the current system can unfairly penalize veterans who diligently manage their conditions with medication or treatment, leading to lower disability ratings than their underlying health issues warrant. By discounting the beneficial effects of treatment, this bill would ensure that veterans receive compensation commensurate with the true severity of their service-connected disabilities, reflecting the reality that many conditions require lifelong management and are not 'cured' by treatment. This change would provide more equitable and stable benefits, recognizing the ongoing impact of their service.
Opponents contend
Opponents might argue that assessing a disability without considering the beneficial effects of treatment could lead to inflated disability ratings, potentially increasing the financial burden on the VA system. They might contend that current treatment regimens are part of a veteran's overall health status, and ratings should reflect the veteran's functional capacity with treatment, as that is their lived reality. Some might also raise concerns about the practical challenges and subjective nature of establishing a 'baseline without beneficial effects,' potentially leading to inconsistencies or increased administrative complexity in the rating process.
The bill is exceptionally short and clear, making it very accessible for any reader to understand its core purpose quickly.
Section 2(b)(1) of the bill, amending 38 U.S.C. 1155.
Discounting Beneficial Effects of Medication or Treatment in Disability Ratings
This provision mandates that when the Department of Veterans Affairs (VA) determines a veteran's disability rating, it must disregard or 'discount' the positive effects of any medication or ongoing treatment. This means the rating should reflect the severity of the disability as if the veteran were not receiving that treatment, provided there is evidence to establish such a baseline. The goal is to ensure veterans are compensated for the true impact of their condition, not just their functional state while actively managing symptoms.
Supporters argue
Supporters argue this provision rectifies an injustice where veterans are penalized for actively managing their health. It ensures that the underlying severity of a service-connected condition, which often requires lifelong treatment, is accurately reflected in their disability rating, rather than their temporary or managed functional state. This leads to fairer and more consistent compensation.
Critics contend
Critics might contend that this approach could lead to an overestimation of disability, as a veteran's functional capacity with treatment is their actual lived experience. They may also argue that establishing a 'baseline without beneficial effects' could be medically complex and subjective, leading to inconsistencies or increased appeals, and significantly increasing the VA's financial obligations.
Tradeoffs
The provision balances the desire to fully compensate veterans for their underlying conditions against the practical and fiscal implications of rating disabilities without considering the functional improvements provided by ongoing medical care. It also creates a tension between a veteran's current functional ability and the theoretical severity of their untreated condition.
Section 2(b)(2) of the bill, amending 38 U.S.C. 1155.
Clarification on Compensation for Treatment-Related Disabilities
This subsection clarifies that the new rule (discounting beneficial treatment effects) does not prevent a veteran from seeking additional disability compensation if the medication or treatment itself causes new disabilities or aggravates existing service-connected conditions. This ensures that veterans are protected from adverse effects of necessary medical interventions.